Heart Test Laboratories, Inc. (HSCS)
NCM · Common · CUSIP 42254E104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for HSCS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
42254E104
Market Cap
Micro Cap
IPO
6/15/2022 · $4.25/unit
Business: Heart Test Laboratories, Inc. d/b/a HeartSciences is medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG’s clinical usefulness. Its first product, the MyoVista Wavelet ECG Cardiac Testing Device, is a resting 12-lead electrocardiograph that uses AI and continuous wavelet transform (CWT) signal processing to provide cardiac information associated with left ventricular diastolic dysfunction, a condition which has previously not been possible to detect using conventional electrocardiology.

Company Contact

CEO
Andrew Simpson
CFO
Danielle Watson
Headquarters
550 Reserve St, Suite 360, Southlake, TX 76092
Phone
682-237-7781
Investor Relations
Gene Gephart · 737-414-9213 · investorrelations@heartsciences.com
General Email
support@heartsciences.com
SEC EDGAR Filings
View filings »